サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467551

アフェレシス市場レポート：成分、製品、技術、施術、用途、エンドユーザー、地域別、2024～2032年

Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBC's ), Product, Technology, Procedure, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アフェレシス市場レポート：成分、製品、技術、施術、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアフェレシス市場規模は2023年に29億米ドルに達しました。今後、IMARC Groupは、市場が2032年までに53億米ドルに達し、2024～2032年の間に6.59%の成長率（CAGR）を示すと予測しています。

アフェレシスとは、様々な疾患を治療するために、赤血球（RBC）、白血球（WBC）、血小板、血漿など、提供された血液成分を分離する手順です。赤血球（RBC）が異常な形をしており、体内で酸素を運ぶことができない鎌状赤血球症の治療に役立ちます。また、血液を濃くし、臓器機能を阻害する異常な白血球（WBC）を除去するためにも使用されます。さらに、血液がんや重症筋無力症、血栓性血小板減少性紫斑病（TTP）などの血液疾患の治療に役立つため、アフェレシスは世界中の採血センター、病院、外来センターで広く使用されています。

アフェレシス市場動向：

自己免疫性溶血性貧血、急性散在性脳脊髄炎、心臓性新生児ループスのような様々な疾患を治療するためのアフェレシスに対する需要の高まりは、市場を牽引する重要な要因の一つです。これに加えて、世界中で火傷患者や外傷患者の治療のために血漿を採取するアフェレシスの利用が増加しています。これは、急成長する医療産業とともに、市場の成長に寄与しています。さらに、閉塞性動脈硬化症の重症型を治療する強化された血液浄化装置を導入するための研究開発活動に対する主要市場参入企業の投資が増加していることも、市場にプラスの影響を与えています。さらに、一次免疫不全症や血友病を治療するための原血漿に対する需要の高まりは、業界の投資家に有利な成長機会を提供しています。これとは別に、血栓性血小板減少性紫斑病、溶血性尿毒症症候群、薬剤毒性、自己免疫疾患、敗血症、劇症肝不全などの様々な疾患の治療法としてアフェレシスの採用が増加しており、市場の展望をポジティブなものにしています。さらに、アフェレシスの利点に関する大衆の意識の高まりが市場の成長を後押ししています。

本レポートで扱う主要質問

  • 2023年のアフェレシス世界市場規模は？
  • 2024～2032年におけるアフェレシス世界市場の予想成長率は？
  • 世界のアフェレシス市場を牽引する主要因は何か？
  • COVID-19が世界のアフェレシス市場に与えた影響は？
  • 世界のアフェレシス市場の成分区分は？
  • 製品別のアフェレシス世界市場内訳は？
  • 技術別のアフェレシス世界市場の内訳は？
  • 施術別のアフェレシスの世界市場内訳は？
  • アフェレシスの世界市場の用途別区分は？
  • エンドユーザー別のアフェレシス世界市場内訳は？
  • アフェレシスの世界市場における主要地域は？
  • 世界のアフェレシス市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のアフェレシス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：成分別

  • 血漿（プラズマフェレシス）
  • 血小板（血小板フェレシス）
  • 白血球（ロイカフェレシスまたはロイコフェレシス）
  • リンパ球（リンパフェレシスまたはリンパフェレシス）
  • 赤血球（赤血球療法）

第7章 市場内訳：製品別

  • デバイス
  • ディスポーザブル・試薬
  • ソフトウェア

第8章 市場内訳：技術別

  • 遠心分離
  • 膜分離
  • 選択吸着

第9章 市場内訳：施術別

  • ドナー/自動アフェレシス
  • 治療アフェレシス

第10章 市場内訳：用途別

  • 腎疾患
  • 血液疾患
  • 神経疾患
  • 自己免疫疾患
  • その他

第11章 市場内訳：エンドユーザー別

  • 血液センター
  • 病院
  • その他

第12章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第13章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第14章 バリューチェーン分析

第15章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第16章 価格分析

第17章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Asahi Kasei Medical Co. Ltd.（Asahi Kasei Corporation）
    • B. Braun SE
    • Charles River Laboratories International Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Haemonetics Corporation
    • Haier Biomedical
    • Kaneka Corporation
    • Medica S.p.a.
    • Miltenyi Biotec
    • Nikkiso Co. Ltd.
    • Sb-Kawasumi Laboratories Inc.（Sumitomo Bakelite Company Limited）
    • Terumo Bct Inc.（Terumo Corporation）
図表

List of Figures

  • Figure 1: Global: Apheresis Market: Major Drivers and Challenges
  • Figure 2: Global: Apheresis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Apheresis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Apheresis Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Apheresis Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Apheresis Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Apheresis Market: Breakup by Procedure (in %), 2023
  • Figure 8: Global: Apheresis Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Apheresis Market: Breakup by End User (in %), 2023
  • Figure 10: Global: Apheresis Market: Breakup by Region (in %), 2023
  • Figure 11: Global: Apheresis (Plasma (Plasmapheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Apheresis (Plasma (Plasmapheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Apheresis (Platelets (Plateletpheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Apheresis (Platelets (Plateletpheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Apheresis (Leukocytes (Leukapheresis or Leukopheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Apheresis (Lymphocytes (Lymphopheresis or Lymphapheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Apheresis (RBC's (Erythropheresis)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Apheresis (RBC's (Erythropheresis)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Apheresis (Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Apheresis (Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Apheresis (Disposables and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Apheresis (Disposables and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Apheresis (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Apheresis (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Apheresis (Centrifugation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Apheresis (Centrifugation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Apheresis (Membrane Separation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Apheresis (Membrane Separation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Apheresis (Selective Adsorption) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Apheresis (Selective Adsorption) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Apheresis (Donor/Automated Apheresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Apheresis (Donor/Automated Apheresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Apheresis (Therapeutic Apheresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Apheresis (Therapeutic Apheresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Apheresis (Renal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Apheresis (Renal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Apheresis (Hematological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Apheresis (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Apheresis (Neurological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Apheresis (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Apheresis (Autoimmune Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Apheresis (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Apheresis (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Apheresis (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Apheresis (Blood Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Apheresis (Blood Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Apheresis (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Apheresis (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Apheresis (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Apheresis (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United States: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United States: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Canada: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Canada: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Asia-Pacific: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Asia-Pacific: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: China: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: China: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Japan: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Japan: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: India: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: India: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: South Korea: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: South Korea: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Australia: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Australia: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Indonesia: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Indonesia: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Europe: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Europe: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Germany: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Germany: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: France: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: France: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: United Kingdom: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: United Kingdom: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Italy: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Italy: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Spain: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Spain: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Russia: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Russia: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Latin America: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Latin America: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Brazil: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Brazil: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Mexico: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Mexico: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Others: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Others: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Middle East and Africa: Apheresis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Middle East and Africa: Apheresis Market: Breakup by Country (in %), 2023
  • Figure 101: Middle East and Africa: Apheresis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Global: Apheresis Industry: SWOT Analysis
  • Figure 103: Global: Apheresis Industry: Value Chain Analysis
  • Figure 104: Global: Apheresis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Apheresis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Apheresis Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Apheresis Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Apheresis Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Apheresis Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
  • Table 6: Global: Apheresis Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Apheresis Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 8: Global: Apheresis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 9: Global: Apheresis Market: Competitive Structure
  • Table 10: Global: Apheresis Market: Key Players
目次
Product Code: SR112024A6477

The global apheresis market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.59% during 2024-2032.

Apheresis is a procedure of separating donated blood components, such as red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma, to treat various diseases. It assists in treating sickle cell disease wherein red blood cells (RBCs) are shaped abnormally and cannot carry oxygen through the body. It is also employed to remove abnormal white blood cells (WBCs) that thicken the blood and interfere with organ function. In addition, as it aids in treating blood cancers and blood disorders, such as myasthenia gravis and thrombotic thrombocytopenic purpura (TTP), apheresis is widely used in blood collection centers, hospitals, and ambulatory centers across the globe.

Apheresis Market Trends:

The growing demand for apheresis to treat various diseases, such as autoimmune hemolytic anemia, acute disseminated encephalomyelitis, and cardiac neonatal lupus, represents one of the key factors driving the market. Besides this, there is a rise in the utilization of apheresis to collect plasma for treating burnt and trauma patients across the globe. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, increasing investments by key market players in research and development (R&D) activities to introduce an enhanced blood purification device that treats severe forms of arteriosclerosis obliterans is positively influencing the market. In addition, the rising demand for source plasma to treat primary immunodeficiency and hemophilia is offering lucrative growth opportunities to industry investors. Apart from this, the growing employment of apheresis as a therapy for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure, is offering a positive market outlook. Additionally, the increasing awareness among the masses about the benefits of apheresis is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global apheresis market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, product, technology, procedure, application and end user.

Breakup by Component:

Plasma (Plasmapheresis)

Platelets (Plateletpheresis)

Leukocytes (Leukapheresis or Leukopheresis)

Lymphocytes (Lymphopheresis or Lymphapheresis)

RBC's (Erythropheresis)

Breakup by Product:

Devices

Disposables and Reagents

Software

Breakup by Technology:

Centrifugation

Membrane Separation

Selective Adsorption

Breakup by Procedure:

Donor/Automated Apheresis

Therapeutic Apheresis

Breakup by Application:

Renal Disorders

Hematological Disorders

Neurological Disorders

Autoimmune Disorders

Others

Breakup by End User:

Blood Centers

Hospitals

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), B. Braun SE, Charles River Laboratories International Inc., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corporation, Haier Biomedical, Kaneka Corporation, Medica S.p.a., Miltenyi Biotec, Nikkiso Co. Ltd., Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited) and Terumo Bct Inc. (Terumo Corporation).

Key Questions Answered in This Report

  • 1. What was the size of the global apheresis market in 2023?
  • 2. What is the expected growth rate of the global apheresis market during 2024-2032?
  • 3. What are the key factors driving the global apheresis market?
  • 4. What has been the impact of COVID-19 on the global apheresis market?
  • 5. What is the breakup of the global apheresis market based on the component?
  • 6. What is the breakup of the global apheresis market based on the product?
  • 7. What is the breakup of the global apheresis market based on the technology?
  • 8. What is the breakup of the global apheresis market based on procedure?
  • 9. What is the breakup of the global apheresis market based on the application?
  • 10. What is the breakup of the global apheresis market based on the end user?
  • 11. What are the key regions in the global apheresis market?
  • 12. Who are the key players/companies in the global apheresis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Apheresis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Plasma (Plasmapheresis)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Platelets (Plateletpheresis)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Leukocytes (Leukapheresis or Leukopheresis)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 RBC's (Erythropheresis)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Disposables and Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Centrifugation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Membrane Separation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Selective Adsorption
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Procedure

  • 9.1 Donor/Automated Apheresis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutic Apheresis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Renal Disorders
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hematological Disorders
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Neurological Disorders
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Autoimmune Disorders
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Blood Centers
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Hospitals
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
    • 17.3.2 B. Braun SE
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Charles River Laboratories International Inc.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 Financials
      • 17.3.3.4 SWOT Analysis
    • 17.3.4 Fresenius Medical Care AG & Co. KGaA
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Haemonetics Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Haier Biomedical
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Kaneka Corporation
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Medica S.p.a.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Miltenyi Biotec
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
    • 17.3.10 Nikkiso Co. Ltd.
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
      • 17.3.10.3 Financials
      • 17.3.10.4 SWOT Analysis
    • 17.3.11 Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
    • 17.3.12 Terumo Bct Inc. (Terumo Corporation)
      • 17.3.12.1 Company Overview
      • 17.3.12.2 Product Portfolio